Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

1.6K
Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.6K
Seizures: Classification01:13

Seizures: Classification

2.1K
Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.1K
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

1.1K
Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.1K
Antiepileptic Drugs: Sodium Channel Blockers01:08

Antiepileptic Drugs: Sodium Channel Blockers

2.2K
Antiepileptic drugs are specialized medications that prevent seizures in individuals diagnosed with epilepsy. These drugs primarily function by blocking the movement of sodium ions through channels in the neuronal membrane, inhibiting the repetitive firing of action potentials often associated with seizures.
Sodium channel blockers modulate ion channels, particularly voltage-gated sodium channels. They block only sodium ion movement.
Among the most commonly prescribed antiepileptic drugs are...
2.2K
Antiepileptic Drugs: Potassium Channel Activators01:20

Antiepileptic Drugs: Potassium Channel Activators

937
Ezocgabine or retigabine, an antiepileptic drug of remarkable efficacy, has revolutionized the management of seizures. It is a potassium channel activator, explicitly targeting the family of Q subtype potassium channels. It enhances the transmembrane potassium currents, regulating neuronal excitability. This action stabilizes the resting membrane potential, a pivotal factor in mitigating the hyperexcitability that characterizes epilepsy.
Ezogabine has gained approval as an adjunctive treatment...
937
Antiepileptic Drugs: GABAergic Pathway Potentiators01:18

Antiepileptic Drugs: GABAergic Pathway Potentiators

1.6K
γ-aminobutyric acid or GABA, plays a pivotal role as an inhibitory neurotransmitter in the brain. GABA pathway potentiators, also known as GABAergic drugs, are a class of pharmaceutical agents designed to enhance the functioning of the GABAergic system. These medications primarily treat epilepsy, a neurological disorder characterized by recurrent seizures.
The key GABA pathway potentiators used in epilepsy management are as follows.
Benzodiazepines are a well-known class of drugs used for...
1.6K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Multiple outlier detection in samples with exponential & Pareto tails.

Journal of applied statistics·2026
Same author

Social feedback amplifies emotional language in online video live chats.

Communications psychology·2025
Same author

Endo-exo framework for a unifying classification of episodic landslide movements: Implications for forecasting catastrophic failures.

Science advances·2025
Same author

The excess volatility puzzle explained by financial noise amplification from endogenous feedbacks.

Scientific reports·2022
Same author

On the use of discrete-time quantum walks in decision theory.

PloS one·2022
Same author

A standardized accelerometry method for characterizing tremor: Application and validation in an ageing population with postural and action tremor.

Frontiers in neuroinformatics·2022

Related Experiment Video

Updated: Mar 25, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.7K

Pharmaco-resistant seizures: self-triggering capacity, scale-free properties and predictability?

Ivan Osorio1, Mark G Frei, Didier Sornette

  • 1Department of Neurology, The University of Kansas Medical Center, Kansas City, KS, USA. iosorio@kumc.edu

The European Journal of Neuroscience
|October 14, 2009
PubMed
Summary
This summary is machine-generated.

Pharmaco-resistant seizures exhibit self-triggering behavior and may be predictable. Their

More Related Videos

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.5K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.4K

Related Experiment Videos

Last Updated: Mar 25, 2026

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale
07:35

Behavioral Characterization of Pentylenetetrazole-induced Seizures: Moving Beyond the Racine Scale

Published on: July 8, 2025

1.7K
Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue
06:45

Generation and On-Demand Initiation of Acute Ictal Activity in Rodent and Human Tissue

Published on: January 19, 2019

9.5K
Pentylenetetrazole-Induced Kindling Mouse Model
07:06

Pentylenetetrazole-Induced Kindling Mouse Model

Published on: June 12, 2018

35.4K

Area of Science:

  • Epilepsy research
  • Computational neuroscience
  • Mathematical modeling

Background:

  • Predictability of seizures and their self-triggering capacity are debated in epileptology.
  • Understanding these dynamics is crucial for effective epilepsy management.

Purpose of the Study:

  • To investigate the predictability and self-triggering capacity of pharmaco-resistant seizures.
  • To apply mathematical tools and a non-reductionist approach to seizure dynamics.

Main Methods:

  • Analysis of prolonged electroencephalogram (EEG) recordings from patients with pharmaco-resistant epilepsy.
  • Estimation of probability distribution functions for seizure energy and inter-seizure intervals.
  • Calculation of conditional seizure probability based on time since the last seizure.

Main Results:

  • Seizure energy and inter-seizure interval distributions follow power laws, indicating scale-free behavior.
  • Pharmaco-resistant seizures demonstrate clustering, with longer seizure-free intervals preceding the next seizure.
  • A few subjects exhibited characteristic size energy probability density functions.

Conclusions:

  • Pharmaco-resistant seizures possess inherent self-triggering capabilities.
  • Power law distributions and self-triggering suggest potential predictability in seizure occurrence and intensity.
  • Scale-free characteristics challenge traditional classifications of seizures based on size and duration.